EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry

Juan Pablo Kaski iD, Gabrielle Norrish iD, Juan Ramon Gimeno Blanes iD, Philippe Charron iD, Perry Elliott iD, Luigi Tavazzi iD, Michal Tendera iD, Cécile Laroche, Aldo P Maggioni iD, Anwar Baban iD, Diala Khraiche, Lidia Ziolkowska iD und 7 weitere

European Heart Journal · 21.04.2024 · 45 (16) · 1443-1454

DOI: 10.1093/eurheartj/ehae109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Heart Journal, online erschienen am 01.03.2024. Verfasst von Juan Pablo Kaski und 18 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Paediatric Inherited and Rare Cardiovascular Disease, University College London Institute of Cardiovascular Science and Great Ormond Stree…. Hauptthemen laut MEDLINE: Myocarditis, Cardiomyopathies, Cardiology, Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Abbott Vascular Int, Amgen Cardiovascular, AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Childhood-onset cardiomyopathies are rare and poorly characterized. This study examined the baseline characteristics and 1-year follow-up of children with cardiomyopathy in the first European Cardiomyopathy Registry.

Methods

Prospective data were collected on individuals aged 1–<18 years enrolled in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis long-term registry (June 2014–December 2016).

Results

A total of 633 individuals aged ≤18 years with hypertrophic [HCM; n = 388 (61.3%)], dilated [DCM; n = 206 (32.5%)], restrictive [RCM; n = 28 (4.4%)], and arrhythmogenic right ventricular cardiomyopathy [ARVC; n = 11 (1.7%)] were enrolled by 23 referral centres in 14 countries. Median age at diagnosis was 4.0 [interquartile range (IQR) 0–10] years, and there was a male predominance [n = 372 (58.8%)] across all subtypes, with the exception of DCM diagnosed <10 years of age; 621 (98.1%) patients were receiving cardiac medication and 80 (12.6%) had an implantable cardioverter-defibrillator. A total of 253 patients (253/535, 47.3%) had familial disease. Genetic testing was performed in 414 (67.8%) patients with a pathogenic or likely pathogenic variant reported in 250 (60.4%). Rare disease phenocopies were reported in 177 patients (28.0%) and were most frequent in patients under 10 years [142 (30.9%) vs. 35 (19.6%); P = .003]. Over a median follow-up of 12.5 months (IQR 11.3–15.3 months), 18 patients (3.3%) died [HCM n = 9 (2.6%), DCM n = 5 (3.0%), RCM n = 4 (16.0%)]. Heart failure events were most frequent in RCM patients (36.0%).

Conclusions

The findings confirm the heterogeneous aetiology of childhood cardiomyopathies and show a high frequency of familial disease. Outcomes differed by cardiomyopathy subtype, highlighting a need for disease-specific evaluation and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocarditisCardiomyopathiesCardiologyCardiomyopathy, HypertrophicChildHumansMaleAdolescentInfant, NewbornInfantChild, PreschoolFemaleProspective StudiesRegistries

Stichwörter der Autor:innen

CardiomyopathyChildGeneticsPaediatricRegistry

Autor:innen und Institutionen

  • Centre for Paediatric Inherited and Rare Cardiovascular Disease, University College London Institute of Cardiovascular Science and Great Ormond Street Hospital NHS Foundation Trust, 20 Guilford Street, WC1N 1DZ London,…
  • Department of Cardiology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
  • Assistance Publique-Hôpitaux de Paris, ICAN, Inserm UMR1166, Sorbonne Université, Centre de Référence des Maladies Cardiaques Héréditaires ou Rares, Hôpital Pitié-Salpêtrière, Paris, France.
  • Centre for Inherited Cardiovascular Diseases, University College London and St. Bartholomew's Hospital, London, United Kingdom.
  • Department of Cardiology, Maria Cecilia Hospital, GVM Care&Research, Cotignola, Italy.
  • Department of Cardiology and Structural Heart Disease, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.

ORCID-Profile: Juan Pablo Kaski, Gabrielle Norrish, Juan Ramon Gimeno Blanes, Philippe Charron, Perry Elliott, Luigi Tavazzi, Michal Tendera, Aldo P Maggioni, Anwar Baban, Lidia Ziolkowska, Giuseppe Limongelli, Tiina Ojala, Matthias Gorenflo, Aris Anastasakis, Shaimaa Mostafa, Alida L P Caforio

Förderung

  • Abbott Vascular Int
  • Amgen Cardiovascular
  • AstraZeneca
  • Bayer AG
  • Boehringer Ingelheim
  • Boston Scientific
  • Bristol Myers Squibb
  • Pfizer Alliance

Zitieren

APA

Kaski, J. P., Norrish, G., Gimeno Blanes, J. R., Charron, P., Elliott, P., Tavazzi, L., Tendera, M., Laroche, C., Maggioni, A. P., Baban, A., Khraiche, D., Ziolkowska, L., Limongelli, G., Ojala, T., Gorenflo, M., Anastasakis, A., Mostafa, S., Caforio, A. L. P., & EORP Paediatric Cardiomyopathy Registry Investigators (2024). Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry. European Heart Journal, 45(16), 1443-1454. https://doi.org/10.1093/eurheartj/ehae109

Vancouver

Kaski JP, Norrish G, Gimeno Blanes JR, Charron P, Elliott P, Tavazzi L, et al. Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry. European Heart Journal. 2024;45(16):1443-1454. doi:10.1093/eurheartj/ehae109

BibTeX
@article{Kaski2024,
  author = {Kaski, Juan Pablo and Norrish, Gabrielle and Gimeno Blanes, Juan Ramon and Charron, Philippe and Elliott, Perry and Tavazzi, Luigi and Tendera, Michal and Laroche, Cécile and Maggioni, Aldo P and Baban, Anwar and Khraiche, Diala and Ziolkowska, Lidia and Limongelli, Giuseppe and Ojala, Tiina and Gorenflo, Matthias and Anastasakis, Aris and Mostafa, Shaimaa and Caforio, Alida L P and EORP Paediatric Cardiomyopathy Registry Investigators, EORP Paediatric Cardiomyopathy Registry Investigators},
  title = {Cardiomyopathies in children and adolescents: aetiology, management, and outcomes in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Registry},
  journal = {European Heart Journal},
  year = {2024},
  volume = {45},
  number = {16},
  pages = {1443--1454},
  doi = {10.1093/eurheartj/ehae109}
}
Kostenlos starten →